House Energy & Commerce member William McKinley (R-WV) hopes to eliminate legal barriers to generic market entry through legislation that would narrow the situations in which brand-drug makers can litigate patents while still maintaining intellectual property protections. The newly introduced bill is a companion to Senate legislation introduced in April . McKinley and bill co-sponsor Rep. Peter Welch (D-VT) pegged the bill as a way to cut back on anticompetitive behavior from the brand-drug industry, and thus increase competition and...